Commerzbank AG upgraded QIAGEN (ETR:QIA) to Buy in a statement released earlier today.
- Updated: September 16, 2016
Yesterday QIAGEN (ETR:QIA) traded 0.00% even at 23.64EUR. QIA’s 50-day average is 0.00EUR and its 200-day moving average is 0.00EUR. With the last close up 0.00% relative to the two hundred day moving average, compared with the S&P 500 Index which has fallen -0.01% over the same time. 0 shares of the stock exchanged hands, from ann avg. trading volume of 0.
Commerzbank AG has upgraded QIAGEN(ETR:QIA) to Buy in a statement released Friday September 16 2016.
See Chart Below:
QIAGEN has a one-year low of 0.00EUR and a 52 week high of 0.00EUR and has a total market value of 0.0 EUR.
Brief Synopsis About QIAGEN (ETR:QIA)
QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, and pharma and academia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.